These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 6399098)
1. [Effectiveness of chemotherapy of advanced forms of neuroblastoma in children according to the program of the RWPG]. Bozek J; Perek D Pediatr Pol; 1984 Nov; 59(11):943-8. PubMed ID: 6399098 [No Abstract] [Full Text] [Related]
2. Neuroblastoma. Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111 [TBL] [Abstract][Full Text] [Related]
3. [Evaluation of efficacy of treatment for 30 children with neuroblastoma]. Sun XF; Liu DG; Su YS; Lin TY; Chen XQ; He YJ Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065 [TBL] [Abstract][Full Text] [Related]
4. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy. Mastrangelo S; Tornesello A; Diociaiuti L; Pession A; Prete A; Rufini V; Troncone L; Mastrangelo R Br J Cancer; 2001 Feb; 84(4):460-4. PubMed ID: 11207038 [TBL] [Abstract][Full Text] [Related]
6. Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol. Valteau-Couanet D; Michon J; Boneu A; Rodary C; Perel Y; Bergeron C; Rubie H; Coze C; Plantaz D; Bernard F; Chastagner P; Bouzy J; Hartmann O J Clin Oncol; 2005 Jan; 23(3):532-40. PubMed ID: 15659499 [TBL] [Abstract][Full Text] [Related]
7. Profile and outcome of neuroblastoma with convertional chemotherapy in children older than one year: a 15-years experience. Bansal D; Marwaha RK; Trehan A; Rao KL; Gupta V Indian Pediatr; 2008 Feb; 45(2):135-9. PubMed ID: 18310793 [TBL] [Abstract][Full Text] [Related]
8. [Combined chemotherapy with alpha interferon for neuroblastoma]. Sawada J; Itoi T; Ishii K; Tanaka T; Matsumura T Gan To Kagaku Ryoho; 1984 May; 11(5):1147-9. PubMed ID: 6721514 [No Abstract] [Full Text] [Related]
9. Effectiveness of moderate dose combination chemotherapy in Burkitt's lymphoma. Patel JG; Pandita R; al-Jazzaf H; Mechl Z; al-Jarallah MA Neoplasma; 1993; 40(3):185-8. PubMed ID: 8350967 [TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of A 1 protocol in advanced neuroblastoma]. Iwafuchi M; Ohsawa Y; Hirota M; Matsuda Y Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1323-8. PubMed ID: 2730045 [TBL] [Abstract][Full Text] [Related]
11. [Multidrug chemotherapy in a 8-year old child with advanced olfactory neuroblastoma]. Cwiklińska M; Balwierz W; Armata J; Załeska-Czepko E Pediatr Pol; 1995 Nov; 70(11):981-3. PubMed ID: 8677167 [TBL] [Abstract][Full Text] [Related]
12. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma. Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885 [TBL] [Abstract][Full Text] [Related]
13. [Value of polychemotherapy in the treatment of children with neuroblastoma]. Czerwiński W; Jurczyk-Procyk S; Ordyniec J; Perek D Probl Med Wieku Rozwoj; 1981; 10():177-87. PubMed ID: 6760183 [TBL] [Abstract][Full Text] [Related]
14. Experience of the Izmir Pediatric Oncology Group on Neuroblastoma: IPOG-NBL-92 Protocol. Olgun N; Kansoy S; Aksoylar S; Cetingul N; Vergin C; Oniz H; Sarialioglu F; Kantar M; Uysal K; Tuncyurek M; Kargi A; Aktas S; Bayol U; Karaca I; Arikan A; Balik E; Aktug T; Elmas N; Kovanlikaya A; Kinay M; Anacak Y; Degirmenci B; Burak Z Pediatr Hematol Oncol; 2003; 20(3):211-8. PubMed ID: 12637217 [TBL] [Abstract][Full Text] [Related]
15. Sequential cis-platinum and VM26 in neuroblastoma: laboratory and clinical (OPEC regimen) studies. Pritchard J; Whelan R; Hill BT Prog Clin Biol Res; 1985; 175():545-55. PubMed ID: 4039448 [No Abstract] [Full Text] [Related]
16. Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma. De Bernardi B; Nicolas B; Boni L; Indolfi P; Carli M; Cordero Di Montezemolo L; Donfrancesco A; Pession A; Provenzi M; di Cataldo A; Rizzo A; Tonini GP; Dallorso S; Conte M; Gambini C; Garaventa A; Bonetti F; Zanazzo A; D'Angelo P; Bruzzi P; J Clin Oncol; 2003 Apr; 21(8):1592-601. PubMed ID: 12697885 [TBL] [Abstract][Full Text] [Related]
17. Localised and unresectable neuroblastoma in infants: excellent outcome with primary chemotherapy. Neuroblastoma Study Group, Société Française d'Oncologie Pédiatrique. Rubie H; Plantaz D; Coze C; Michon J; Frappaz D; Baranzelli MC; Chastagner P; Peyroulet MC; Hartmann O; Med Pediatr Oncol; 2001 Jan; 36(1):247-50. PubMed ID: 11464897 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of patients with advanced neuroblastoma surviving more than 5 years after initiation of an intensive Japanese protocol: a report from the Study Group of Japan for Treatment of Advanced Neuroblastoma. Iwafuchi M; Utsumi J; Tsuchida Y; Kaneko M; Matsuyama S; Ohnuma N; Taguchi N; Mugishima H; Yokoyama J; Sasaki S; Yoshioka A; Nagahara N; Fukuzawa M; Suita S Med Pediatr Oncol; 1996 Dec; 27(6):515-20. PubMed ID: 8888810 [TBL] [Abstract][Full Text] [Related]
19. Pneumocystis carinii pneumonia: a late presentation following treatment for stage IV neuroblastoma. Clarke E; Glaser AW; Picton SV Pediatr Hematol Oncol; 2003 Sep; 20(6):467-71. PubMed ID: 14631621 [TBL] [Abstract][Full Text] [Related]